Clinical efficacy of Apatinib combined with Epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) in nonsmall cell lung cancer after EGFR-TKI resistance

Ruifen Tian(Shanxi Provincial Cancer Hospital), Xia Song(Shanxi Provincial Cancer Hospital), Xing Zhang(Nanjing University of Chinese Medicine), Xia Zhang(Army Medical University), Yi Guo(Chongqing Emergency Medical Center)
Pakistan Journal of Medical Sciences
July 29, 2024
10.12669/pjms.40.8.9682
Cited by 0

Related Papers

Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway
|Molecular Cancer|2019|902
RETRACTED ARTICLE: Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis
|Journal of Experimental & Clinical Cancer Research|2018|109
Toll-Like Receptor -1, -2, and -6 Polymorphisms and Pulmonary Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis
|PLoS ONE|2013|92
The landscape of immune microenvironment in lung adenocarcinoma and squamous cell carcinoma based on PD‐L1 expression and tumor‐infiltrating lymphocytes
|Cancer Medicine|2019|56
The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastro­intestinal tract cancer: a systematic review and meta-analysis
|OncoTargets and Therapy|2015|31